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One must imagine Sisyphus happy 
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ABSTRACT 
Long non-coding RNAs (lncRNAs) constitute a heterogeneous class of RNAs with limited 
coding potential, united by an arbitrarily placed cut off of >200 ntd. The past decade has seen 
the emergence of lncRNAs as versatile regulators of gene expression, amidst skepticism 
regarding the biological usefulness of pervasive genomic transcription and its non-coding 
RNA products prevalent in most eukaryotes. A significant portion of lncRNAs operate in the 
development and functioning of the mammalian CNS. Oligodendrocytes (OLs) are the 
myelinating cells of the CNS that are essential for efficient saltatory conduction and axonal 
survival. They are derived from OL precursors (OPCs) and progress into transcriptomically 
heterogeneous OL sub-populations along the differentiation pathway to produce mature OLs, 
capable of myelination. These epigenetic transitions between different OL subpopulations are 
carefully regulated, spatially and temporally, by a network of transcription factors, chromatin 
modulators and lncRNAs. In demyelinating diseases like multiple sclerosis (MS), patients 
suffer immune mediated attacks against myelin. Eventually, remyelination strategies fail due 
to deficits in OPC migration and OL differentiation at the site of lesions. Thus, understanding 
molecular mechanisms governing OL differentiation and myelination is crucial not only  for 
understanding OL function in health but also in disease, in order to develop suitable 
therapeutic interventions.    
The investigations presented in this thesis explore the role of lncRNAs and RNA-binding 
proteins in neurodevelopment, particularly in embryonic stem cells (ESCs) and cells of the 
OL lineage.  
Article 1 provides a resource for the protein interactome of a key pioneering transcription 
factor, Sox2, in different nuclear fractions of mouse ESCs. We found Sox2 to be a multi-
faceted regulator forming interactions with HP1 family of proteins, whose members perform 
as both activators and repressors in a context dependent manner. In addition to interacting 
with RBPs involved in post-transcriptional processes, Sox2 also interacted with Rn7sk, a 
well-known ncRNA involved in the regulation of transcriptional elongation at promoters and 
enhancers. Although they did not influence each other‘s recruitment to the chromatin, this 
interaction opens up the possibility for ncRNA mediated modulation of ES transcriptional 
programs dependent on Sox2.  
Article 2 draws important insights regarding lncRNAs from a broad transcriptomic resource 
established from single cell- as well as bulk RNA- sequencing of OL lineage cells from 
different developmental stages. From a subset of lncRNAs which were found to be specific 
for certain OL subpopulations, we investigated the role of 2610035D17Rik in modulating the 
expression of its neighboring gene, Sox9, a transcription factor essential for OPC 
specification. We decoupled the role of lncRNA transcript from its genomic locus using 
various loss-of-function strategies and found that the regulation of Sox9 was dependent on 
the regulatory elements and/or ongoing transcription at the 2610035D17Rik locus, rather than 
the transcript itself. 
In Article 4, we investigated a hitherto unexplored RNA-binding function of myelin gene 
expression factor 2 (Myef2), a known transcriptional repressor of myelin basic protein 
(MBP). To this end, we uncovered the RNA interactome of Myef2 in a mouse 
oligodendroglial cell line with individual nucleotide resolution CLIP (iCLIP) followed by 
sequencing. We show that Myef2 interacts with CUG motifs located within introns and 
3‘UTRs of protein-coding genes, a finding which implicates Myef2 in post-transcriptional 
processes like splicing and RNA stability.   
Finally, in Article 3 we have identified disease specific transcriptomic profiles of OL lineage 
cells through single-cell RNA sequencing of OPCs and OLs derived from experimental 
autoimmune encephalomyelitis (EAE) mice, a model that recapitulates several aspects of MS. 
EAE specific OPC and OL clusters were enriched for genes involved in antigen processing 
and presentation (MHC class I/II). We could demonstrate that OPCs can phagocytose myelin 
debris and MHC-II-expressing OPCs can activate memory and effector CD4-positive T cells. 
These findings show OL lineage cells as active participants in MS pathology than passive 
targets. Further, the findings of Article 2 implicate 2610035D17Rik as a regulator of 
immunomodulatory properties of oligodendroglia, as 2610035D17Rik KO cells showed 
reduced expression of IFNγ responsive genes and elevated expression of those involved in 
antigen presentation, compared to the controls, following IFNγ stimulation. 
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1 INTRODUCTION TO LONG NON-CODING RNAS 
1.1 HISTORICAL OVERVIEW 
Concepts making up the framework of RNA biology have undergone tremendous changes 
since its conception; certain fundamental assumptions have been overturned in the process of 
attaining current insights regarding the pivotal role of RNA in shaping gene expression. The 
involvement of house-keeping non-coding RNAs (ncRNAs) such as ribosomal RNA (rRNA) 
and transfer RNAs (tRNAs) in protein synthesis were well established as early as 1950s. The 
discovery of catalytically active ribozymes and small nuclear RNAs (snRNAs) involved in 
intron excision (Kruger et al., 1982; Lerner et al., 1980) came nearly three decades after and 
strengthened the possibility of RNA acting as a catalytic entity of ribosomal unit (Steitz and 
Jakes, 1975). These discoveries added to the growing speculation that RNA could be 
something more than a passive purveyor of genetic information. Further, the discovery of a 
short RNA in C.elegans that could base-pair imperfectly with its target mRNA and down-
regulate it during development (Lee et al., 1993) and its similarity with the 20-22 ntd RNA-
mediated silencing observed in worms and plants (Fire et al., 1998; Hamilton and 
Baulcombe, 1999), now called miRNAs and siRNAs respectively, gave an unprecedented 
impetus to the field and paved the way towards understanding a RNA dependent post-
transcriptional regulatory mechanism widespread in eukaryotes. Other classes of small 
ncRNA regulators that have been identified since are small nucleolar RNAs (snoRNAs) that 
aid in chemical modification of other RNAs (Bachellerie et al., 1995) and piwi-interacting 
RNAs (piRNAs) that maintain genomic integrity by repressing retrotransposition of repeat 
elements (Siomi et al., 2011). Most recent addition to this list are a heterogeneous class of 
ncRNAs called the long non-coding RNAs (lncRNAs) which are distinguished from above 
said small ncRNAs with an arbitrarily placed cut off of >200 ntd. 
1.2 FUNCTIONAL PRODUCT OR TRANSCRIPTIONAL NOISE? 
Recent advances in transcriptomic profiling, especially microarray/tiling and deep sequencing 
technologies, made it possible to look at mammalian RNA species in much greater detail. 
Global genomics consortia such as FANTOM and ENCODE started in early 2000 revealed 
protein coding genes accounted for only a small fraction of the genome, making ncRNAs a 
major component of mammalian transcriptomes (Carninci et al., 2005; ENCODE Project 
Consortium et al., 2007; Okazaki et al., 2002). Later projects uncovered a comprehensive 
catalogue of transcription start and termination sites, with promoters also mapped within 
exons and 3‘UTRs of coding genes (Carninci et al., 2006; Katayama et al., 2005). Usage of 
different combinations of exons and polyA sites seemed commonplace, with even non-coding 
transcripts producing alternative forms (Ravasi et al., 2006). This unexpected transcriptomic 
complexity generated an interest regarding the possibility of non-coding RNA based 
regulatory systems principally driving organismal complexity (Mattick, 2004). But despite 
pervasive transcription and such diversity, only a small number of non-coding transcripts 
have known functions, lncRNAs being the least understood products of transcription. 
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A pertinent question that arises in the light of such a discovery is whether these 
transcriptional products are biologically meaningful or constitute mere ‗transcriptional noise‘. 
It is known that the transcriptional machinery is slippery and open chromatin could be easily 
transcribed into products that serve no purpose (Struhl, 2007), some of which could also be 
capped and spliced out of chance and tolerated because of minimal fitness cost to the cell. 
Some transcripts may be produced coincidentally with the act of transcription that occurs at 
certain regulatory DNA elements in the genome and may not be functional by themselves 
(Kornienko et al., 2013). The possibility remains that a substantial fraction of the non-coding 
transcriptome might indeed be non-functional but with growing lncRNA numbers and their 
associated functional diversity (Ramilowski et al.,bioArxiv 2019),  it seems increasingly 
likely that they are biologically important. 
1.3 CLASSIFICATION  
Annotation for a disparate class of molecules united by an arbitrary cut off size of > 200 ntd 
has just begun and hence there is a need for a universal standardized system of lncRNA 
classification. The HUGO Gene Nomenclature Committee (HGNC) guidelines (Wright, 
2014) recommend naming a lncRNA as an abbreviation of a descriptive name, preferably 
based on its function (E.g. NEAT1 - nuclear paraspeckle assembly transcript 1). LncRNAs 
with no known function are named based on their genomic context, in relation to adjacent 
protein-coding genes. For example, Overlapping (OT) lncRNAs encompass a protein coding 
gene or parts of it within them, on the sense or antisense (AS) strand, respectively. Intronic 
(IT) lncRNAs come from within an intron of a protein coding gene and do not overlap with 
any exons. Antisense Upstream (AU) or bidirectional lncRNA and a protein coding gene are 
transcribed divergently from the same or closely situated TSS. Intergenic or Long Intervening 
ncRNAs (LINC) lie between protein coding loci. 
In addition to above classification, other lncRNA classes associated with promoters are found 
in literature, and are distinguished based on their length. For example, the shortest amongst 
them (<100 ntd) are called transcription start site associated RNAs (TSSa-RNA) and are 
likely to be degradation products of nascent RNA (Valen et al., 2011). Longer transcripts 
produced divergently from a productive Pol II elongation are called promoter upstream 
transcripts (PROMPTs) and they undergo degradation by nuclear exosome (Kapranov et al., 
2007). Transcripts arising from regulatory enhancer regions are enhancer RNAs (eRNAs) and 
activating ncRNAs (ncRNA-a) (Santa et al., 2010). 
1.4 ORIGIN 
LncRNAs are thought to originate via several mechanisms. Homologous lncRNAs are born 
when there is duplication of sequence containing a functional lncRNA locus. It is possible for 
a duplicated protein coding gene to undergo metamorphosis by accumulating mutations that 
disrupt the ancestral open reading frame to give rise to a pseudogene, which when transcribed 
produces a lncRNA (Pei et al., 2012; Zheng et al., 2007). Such pseudogenisation can also 
occur on unitary protein coding genes resulting in a lncRNA with no apparent protein-coding 
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homologue (Marques et al., 2012). Yet another mechanism of lncRNA birth is the integration 
of RNA derived from transposable elements into non-coding genes. Mostly defunct 
transposable elements are found within lncRNAs, with retrotransposons contributing to 
almost two thirds of mature mouse and human lncRNA sequences (Kapusta et al., 2013). 
They are more likely to provide functional cis-elements such as a transcription start site, 
polyadenylation and splice sites to lncRNA genes compared to protein coding loci (Kapusta 
et al., 2013). LncRNAs can also arise de-novo when pervasive transcription from non-coding 
DNA results in cryptic RNAs and if they pass through evolutionary selection, become 
transcripts with novel functions (Heinen et al., 2009). 
1.5 EVOLUTIONARY CONSERVATION 
Generally, genomic sequences of lncRNAs have low evolutionary constraints, unlike protein 
coding genes (Kowalczyk et al., 2012). Criterion based on primary sequence conservation has 
given rise to considerable skepticism regarding the biological significance of lncRNAs but 
this consideration alone might be restrictive. Indeed, lncRNAs show more conservation in 
their exons and splice sites than repeat elements under neutral evolutionary pressure 
(Ponjavic et al., 2007). In fact, lncRNA promoters were found to be as conserved as those of 
protein coding genes (Derrien et al., 2012; Guttman et al., 2009).  LncRNAs that do share 
such limited homology amongst vertebrates are the lincRNA subfamily, often found to be 
actively regulated with similar expression patterns as protein coding genes involved in tissue 
specific functions (Hezroni et al., 2015; Necsulea et al., 2014). Those with no detectable 
sequence conservation still show conserved genomic locations or synteny (Ulitsky et al., 
2011). Thus low conservation might be a result of rapid turnover of lncRNAs, given their 
shallow evolutionary origin compared to protein-coding genes or it could be due to 
evolutionary constraints acting over a small region buried within a long transcript.  
1.6 BIOGENESIS AND PROCESSING 
Most eukaryotic lncRNAs are transcribed by RNA pol II, from open chromatin/DNase 
hypersensitive regions, and require canonical transcriptional machinery. Accordingly, histone 
signatures include H3K4me3 at linc promoters and H3K36me3 over the transcript body, 
which is similar to what is observed for protein coding genes (Guttman et al., 2009). 
LncRNA genes that overlap with enhancers exhibit H3K27ac epigenetic mark and a higher 
ratio of H3K4me1/ H3K4me3 in their transcription initiation regions (Kim et al., 2015). 
PROMPTs however are predominant at CpG rich promoters, do not extend into nucleosome 
depleted regions and are generally devoid of transcription initiation factors such as TAFI, 
TAFII p250 and E2F1 (Preker et al., 2011). 
Many lncRNAs are capped at the 5‘ end, although intronic lncRNAs comprise a higher 
percentage of uncapped transcripts (Ayupe et al., 2015). While mRNAs undergo robust co-
transcriptional splicing and polyadenylation, lncRNAs show decreased splicing and are 
biased towards having two exons and longer introns (Derrien et al., 2012). Decreased splicing 
in lincRNAs may be due to the presence of weaker 3‘ splice signals and less binding by the 
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splicing factor U2AF65 (Melé et al., 2017). Furthermore, transcription termination mark in 
the form of phosphorylated Thr4 on RNA pol II CTD seems to be found across entire 
lincRNA transcriptional units (Schlackow et al., 2017). A study has also reported an 
asymmetric enrichment in polyadenylation sites (PASs) in antisense lincRNAs transcribed 
from bidirectional promoters, which would favour their premature transcription termination 
(Almada et al., 2013). LncRNAs may or may not possess a 3‘ poly-adenylated tail and in 
some cases could even be bimorphic and exist in both polyA+ and polyA- forms (Yang et al., 
2011). Additionally, they exhibit a wide range of half-lives, with the median lncRNA half-life 
(3.5 hours) being slightly less than that of mRNAs (5.1 hours) (Clark MB, Genome Res 
2012). Amongst different lncRNA classes, intergenic and cis-antisense transcripts were found 
to be more stable than intronic lncRNAs and PROMPTs (Clark et al., 2012). Thus, splicing, 
poly-adenylation and specific 3‘ structures such as the triple helix accord higher stability to 
lncRNAs (Clark et al., 2012; Wilusz, 2016). LncRNAs are lowly expressed, the median 
expression being almost a tenth of mRNAs‘ (Cabili et al., 2011; Ulitsky et al., 2011) but their 
expression seems more restricted to a particular tissue/cell type or developmental stage 
(Batista and Chang, 2013).  
Most lncRNAs lack robust ORFs (Mercer et al., 2009). Data from ribosome profiling 
however shows a considerable fraction of lncRNAs to be associated with ribosomes (Bazzini 
et al., 2014; Ingolia et al., 2011),  in a pattern indicative of their potential to produce short 
peptides. Bioinformatic analysis of ribosome profiling data from two cell-lines has identified 
translated ORFs in over 500 lncRNAs (Ji et al., 2015).  However, it has been pointed out that 
ribosome occupancy alone cannot distinguish non-coding from protein coding transcripts, as 
classical ncRNAs also engage the ribosomes at their 5‘UTR. Further, non-coding RNAs do 
not show ribosome release from any of their ORFs, an event that occurs consistently at the 
stop codons of protein coding genes (Guttman et al., 2013).  Although the proportion of  
lncRNAs that can encode peptides is debatable, it has become clear that some lncRNAs 
harbour short ORFs (sORFs) that are translatable into micropeptides of < 100 aa (Mumtaz 
and Couso, 2015), examples of which have recently come to light (Choi et al.). 
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2 LNCRNA FUNCTION 
Only a fraction of lncRNAs have been well characterized; they are very heterogeneous in 
their mode of action and are known to operate at multiple levels of gene expression 
regulation. 
2.1 TRANSCRIPTIONAL REGULATION 
Many lncRNAs localize to the nucleus preferentially (Quinodoz and Guttman, 2014; Vance 
and Ponting, 2014). Though the global determinants of lncRNA nuclear localization is still 
unclear, it has been mainly linked to inefficient splicing (Zuckerman and Ulitsky, 2019) and 
presence of integrated Alu elements along with HNRNPK binding (Lubelsky and Ulitsky, 
2018). In addition, specific motifs have been identified in individual lncRNAs that play a role 
in their nuclear retention (Miyagawa et al., 2012; Zhang et al., 2014a). 
The mode of lncRNA action in the nucleus could be dependent on the act of transcription 
rather than the transcript itself, where transcription of lncRNA induces local chromosomal 
remodelling affecting the binding of regulatory factors which could in turn influence gene 
expression in the vicinity (Camblong et al., 2007). Alternatively, the lncRNA transcript could 
directly recruit multiple regulatory complexes by making use of its discreet domains or larger 
structure, targeting them to a specific DNA locus. In the latter case, lncRNA can act either in 
–cis (at/near the site of its transcription) or in –trans (away from the site of its transcription), 
though the three-dimensional (3D) scape of the genome sometimes blurs this distinction. 
2.1.1 Imprinting 
During early mammalian gametogenesis, some protein coding genes are epigenetically 
marked such that their expression occurs in a parent of origin specific manner in a process 
known as genomic imprinting. LncRNAs expressed from differentially methylated 
―imprinting control regions‖ usually enact imprinting on gene clusters via cis-regulatory 
mechanisms. For example, the expression of nuclear localized lncRNA Kcnq1ot1 is restricted 
to the paternal chromosome and upon its transcription recruits chromatin and DNA 
methyltransferases (G9a, DNMT1) to silence the Kcnq1/Cdkn1c gene cluster in cis, while 
their maternal alleles continue to be expressed (Kanduri, 2016). 
One of the best-studied examples of imprinting is that of 17kb lncRNA Xist that dramatically 
silences one of the female X chromosomes (Xi) from which it is expressed (Jonkers et al., 
2008), thereby providing dosage compensation. Other lncRNA partners involved in mouse X-
chromosome inactivation (XCI) are Xist activators, Jpx and Ftx, along with Tsix, a Xist 
repressor. Tsix is transcribed anti-sense to Xist on the active X chromosome (Xa), thereby 
protecting it from ectopic XCI (Gayen et al., 2015). While Jpx lncRNA acts in either cis or 
trans to bind and remove the insulator protein, CTCF, from repressing Xist (Sun et al., 
2013b), transcription in the Ftx lncRNA locus leads to expression of Xist in cis (Furlan et al., 
2018). This establishment of monoallelic Xist expression triggers a cascade of events where 
Xist gradually spreads from its transcription locus by binding to a scaffold attachment factor, 
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drawing in more distant regions on XI while using its modular domains to recruit multiple 
epigenetic regulators (HDAC3, PRC2/1, SETDB1) that help in initiating and maintaining 
transcriptional repression through histone deacetylation and methylation, respectively (Cerase 
et al., 2015).  
2.1.2 Enhancer mediated regulation 
Enhancers are decompacted DNA elements capable of binding transcription factors and co-
activator complexes; they drive gene expression independently of the distance and orientation 
of their target promoters and are epigenetically marked with a higher H3K4me1/ H3K4me3 
ratio (Li et al., 2016). Active enhancers often give rise to bi-directional, unspliced, non-
polyadenylated transcripts (Kim et al., 2015) and sometimes relatively more directional, 
polyadenylated transcripts (Koch et al., 2011), termed as enhancer RNAs (eRNAs) and 
activating ncRNAs (ncRNA-a), respectively. The production of eRNAs is highly regulated 
and often precedes the induction of adjacent mRNAs in response to a certain stimulus (Kim 
et al., 2015; Li et al., 2016; Wang et al., 2011). However, successful eRNA induction seems 
to be dependent on the RNA endonuclease activity of the Integrator complex, which is 
involved in 3‘ cleavage of the eRNA transcript (Lai et al., 2015).  
The activating function of eRNAs sometimes appears to be sequence specific as reported by 
enhanced gene expression in a plasmid reporter system in which eRNAs were tethered 
upstream of its minimal promoter (Lam et al., 2013). In other cases, they seem to stabilize 
and strengthen enhancer-promoter looping through cohesin (Li et al., 2013) and the mediator 
complex (Kagey et al., 2010; Lai et al., 2015) as well as facilitate RNA pol II loading or 
productive elongation at the target gene promoter (Mousavi et al., 2013; Schaukowitch et al., 
2014). Thus eRNAs and/or active enhancer transcription regulates genomic accessibility, 
transcription machinery availability, chromatin conformation locally and in highly specific 
ways to drive cell type and activity dependent expression programs. 
2.1.3 Modulation of transcriptional machinery  
LncRNAs can directly act on the transcriptional machinery. In one case, a lncRNA generated 
from short interspersed elements (SINEs) during heat shock blocks transcription by binding 
to RNA pol II, by entering into transcriptional complexes at promoters (Mariner et al., 2008). 
Alternatively, lncRNAs can form stable triplexes with promoters and regulate binding of 
transcriptional activators or inhibitors in trans, as in the case of lncRNA Khps1 that forms a 
triplex with a homopurine stretch upstream of SPHK1 (Sphingosine kinase 1) promoter and 
activates it by recruiting histone acetyl transferase p300/CBP54 (Postepska-Igielska et al., 
2015).  They can also interact with transcription factors and help in their recruitment to 
specific gene sets as in the case of lncRNA RMST (rhabdomyosarcoma 2-associated 
transcript) and SOX2 co-regulating neural stem cell fate (Ng et al., 2013). 
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2.1.4 Nuclear architecture 
Recent studies have shown that lncRNAs actively assemble and maintain nuclear domains. 
Paraspeckles are transcription dependent dynamic foci that are enriched with RNA-binding 
proteins (RBPs) involved in RNA splicing, editing and DNA unwinding (Bond and Fox, 
2009). Though their function is not entirely known, it is possible that they provide an ordered 
pool of their component proteins and help in directing their activity when required (Schuldt, 
2002). Along with RBPs, they also harbour lncRNA NEAT1 that is crucial for paraspeckle 
structural integrity, so much so that knock down of NEAT1 results in paraspeckle dispersion 
(Clemson et al., 2009) and an artificial tethering of NEAT1 to a genomic location is sufficient 
for paraspeckle formation (Shevtsov and Dundr, 2011). Interestingly, paraspeckle formation 
also seems to be dependent on ongoing NEAT1 transcription, and not just the presence of the 
lncRNA (Mao et al., 2011). Further, some adenosine-to-inosine edited mRNAs, along with 
those that contain Alu repeats, associate with paraspeckles and it is speculated that NEAT1 
might play a role in their nuclear retention (Chen and Carmichael, 2009). Another lncRNA 
called MALAT1/NEAT2 is a part of nuclear speckles; a storehouse for pre-mRNA processing 
proteins (Lamond and Spector, 2003). Although MALAT1 is not required for nuclear speckle 
integrity, it seems to have a role in ensuring proper localization of some nuclear speckle 
proteins involved in splicing (Tripathi et al., 2010). It has been proposed that MALAT1 
scaffolds actively transcribing genes (West et al., 2014) to nuclear speckles and its contents to 
influence gene expression (Engreitz et al., 2016)  
LncRNAs can also be involved in modulating higher order nuclear architecture. For example, 
lncRNA Firre localises across a X chromosome domain that escapes inactivation and forms 
high-affinity interactions with DNA loci on different mouse chromosomes (Hacisuleyman et 
al., 2014). This trans-chromosomal co-localisation brings genes involved in energy 
metabolism and/or adipogenesis together in 3D space to facilitate their co-regulation (Sun et 
al., 2013a). The capacity of lncRNAs to passively diffuse while acting as bridging molecules 
between transcribing DNA and different proteins combined with the ability of certain self-
interacting RBPs to segregate into phase separated bodies, most likely drives nuclear 
compartmentalization (Kato et al., 2012; Yamazaki et al., 2018). 
2.2 POST-TRANSCRIPTIONAL REGULATION 
lncRNAs also function as effective modulators of post-transcriptional processes like pre-
mRNA splicing, mRNA decay, and translation, in addition to their roles as transcriptional 
regulators. 
2.2.1 mRNA splicing and stability 
There has been a growing appreciation of the ways in which chromatin status and 
transcription is coupled to splicing events (Montes et al., 2012) and lncRNAs seem to play a 
role in bridging these regulatory systems. For example, a nuclear anti-sense lncRNA from the 
FGFR2 locus was shown to promote alternative splicing of FGFR2 mRNA into an epithelial-
specific isoform by recruiting polycomb proteins and histone demethylase (KDM2a), which 
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impair mesenchymal-specific splicing by abrogating the binding of a repressive chromatin-
splicing adaptor complex (Gonzalez et al., 2015). In addition, lncRNAs can influence splicing 
outcomes by sequestering RNA-binding proteins involved in splicing regulation. One such 
example is a new class of intron-derived lncRNAs, called sno-lncRNAs, which are flanked 
by small nucleolar RNA (snoRNA) sequences and lack 5‘ cap and polyA tail. Particularly, 
those derived from the 15q11-q13 human chromosomal region implicated in Prader-Willi 
syndrome (Duker et al., 2010), harbour multiple binding sites for the alternative splicing 
regulator FOX2 and act as a molecular sink to prevent its binding to other mRNA targets 
(Yin et al., 2012).  
LncRNAs can act as both positive and negative regulators of mRNA stability. For example, 
Alu-repeat containing lncRNAs form imperfect base pairing with the Alu elements in the 3‘ 
UTRs of their target mRNAs which is recognized by Staufen 1 (STAU1) to induce staufen-
mediated decay (Gong and Maquat, 2011). By contrast, a lncRNA transcribed antisense to 
beta-secretase producing BACE1 mRNA, forms a duplex with the mRNA and abrogates miR-
485-5p induced repression, thereby stabilizing its target mRNA (Faghihi et al., 2010). 
2.2.2 Translation 
The mouse ubiquitin carboxyterminal hydrolase L1 (Uchl1) mRNA encodes an enzyme with 
roles in brain development and shares complementarity at its 5‘ end with a neuron specific, 
nuclear enriched, antisense (AS) Uchl1 lncRNA. Upon mTORC1 inhibition, it was found that 
Uchl1-AS translocates to the cytoplasm, and through overlapping complementarity, enhanced 
the formation of active polysomes on its target mRNA and therefore its translation (Carrieri 
et al., 2012). 
2.2.3 Encoding small peptides 
Some lncRNAs harbor sORFs that are translatable, and a few of the resulting peptides have 
been reported to be biologically active. SPAR is a lncRNA encoded small peptide <100 aa 
that inhibits mTORC1 activation necessary for muscle regeneration (Matsumoto et al., 2017).  
Minion, another sORF peptide was found to be critical for the induction of mononuclear 
progenitor fusion into multinuclear myotubes during skeletal muscle development (Zhang et 
al., 2017b). In addition to peptides functioning in muscles, a cancer related peptide, HOXB-
AS3, inhibits hnRNPA1 mediated splicing of pyruvate kinase M (PKM) and suppresses 
glucose metabolism needed for supplying energy to tumors (Huang et al., 2017). 
2.2.4 Regulatory sponges 
Circular RNAs (circRNAs) are created when a splice donor at the 3‘ exon end is joined to a 
5‘ splice acceptor of an upstream exon in a non-canonical splicing event called ‗backsplicing‘ 
(Memczak et al., 2013; Salzman et al., 2012). CircRNAs are stable and accumulate in the 
cytoplasm without associating with ribosomes (Guo et al., 2014), however exceptions have 
been reported recently. CircRNAs were found to undergo translation especially in response to 
stimuli that interferes with cap dependent translation (Legnini et al., 2017; Pamudurti et al., 
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2017). Known functions of circRNAs till date include their ability to act as miRNA sponges. 
For example, cerebellar degeneration-regulated protein 1 anti-sense RNA (CDR1-AS) 
contains more than seventy miR-7 binding sites and is resistant to miRNA mediated 
destabilization, resulting in an increased expression of miR-7 targets (Hansen et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Modes of lncRNA action 
From left to right– LncRNAs can regulate transcription in the nucleus by mediating enhancer looping, by acting 
as scaffolds for chromatin modifying complexes, modulating activity of transcription factors and by influencing 
spatial conformation of chromosomes. In the cytoplasm, circRNAs can sequester miRNAs, some cytoplasmic 
lncRNAs carry small ORFs that can be translated into biologically active small peptides and they can regulate 
mRNA stability or translation. (Adapted from Moralando et al.,2015)  
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3 TECHNOLOGICAL ADVANCES 
3.1 IDENTIFICATION OF LNCRNAS 
Deep sequencing methodologies in the last decade have revolutionized the way we 
understand the transcriptomic output of cells and consequently their functional states. 
Predictably, the most commonly employed technique to discover novel lncRNAs and 
quantify their expression is bulk RNA-sequencing (RNA-seq) Usually rRNA-depleted 
transcriptomes from large cell populations are reverse transcribed with random primers into a 
pool of cDNAs, which are then sequenced. The total RNA-seq libraries thus obtained are 
enriched for both polyadenylated and non-polyadenylated transcripts and the resulting data is 
representative of average gene expression pattern across millions of cells. Given that 
heterogeneity of gene expression is observed even within same cell populations and could 
harbour biologically relevant information, single-cell RNA sequencing (scRNA-seq) was 
developed to address this concern (2014).  Broadly, this technique involves isolating single 
cells via fluorescence activated cell sorting (FACS) or microfluidics followed by capturing 
and barcoding their transcripts. Reverse transcription and amplification of cDNAs then 
generate libraries in which the transcripts can be mapped back to individual cells.  Cap 
analysis of gene expression (CAGE) is another high-throughput method that relies on the 
presence of 5‘ cap on RNAs to identify active promoter regions and TSS driven by Pol II, as 
such excludes non-capped transcripts and circRNAs (Shiraki et al., 2003). While RNA-seq 
and CAGE measure steady state RNA levels, methods like global run-on sequencing (GRO-
seq) target nascent RNA transcription from actively engaged polymerases (Lopes et al., 
2017). This genome wide snapshot of transcription is particularly suited for lncRNAs that 
have a high decay rate (Chu et al., 2015). 
3.2 LNCRNA FUNCTION 
Subcellular localization of lncRNAs can potentially hold clues about their function. In-situ 
hybridization (ISH) techniques can detect and localize target RNAs within cells by using 
complementary probes. This is followed by visualization with fluorescence microscopy, 
either with direct labeling of probes with fluorophores (single molecule RNA FISH) (Kwon, 
2013) or with signal amplification schemes (RNAscope) (Wang et al., 2012). Recently 
developed technologies like fluorescent in situ RNA-seq (FISSEQ) (Lee et al., 2014) have 
combined transcriptomic data from sequencing with spatial information from ISH to achieve 
cell or tissue specific visualization of lncRNA expression and localization. 
As discussed above, many lncRNAs function by interacting with protein partners. One of the 
methods to investigate RNA-protein complexes in-vivo with high positional resolution is to 
use UV mediated crosslinking and immunoprecipitation followed by high throughput 
sequencing (CLIP-seq) (Ule et al., 2003). Any interacting RNA covalently fixed to the 
protein of interest is partially digested and this complex is pulled down using an antibody 
against the protein. Following immunoprecipitation, RNA is reverse transcribed and the 
protein content is digested before the preparation of cDNA libraries for sequencing. One of 
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the limitations of CLIP is the loss of a large fraction of truncated cDNAs lacking the 5‘ 
adapter due to reverse transcriptase stalling at the peptide residue left at the site of cross-
linking while proceeding from the 3‘ adapter end.  A particular variant of CLIP called 
individual nucleotide resolution CLIP (iCLIP) (König et al., 2010) resolves this problem by 
circularizing cDNAs containing cleavable adapters which when linearized generates 
templates that can be captured for PCR amplification. These techniques have been widely 
used to generate transcriptome wide binding maps for many RBPs, particularly those 
involved in post-transcriptional gene regulation, in order to characterize their molecular 
function.  
LncRNAs also function by interacting with DNA directly or through protein intermediates. 
Thus many genomic-context based methodologies have been developed to unravel lncRNA 
chromatin occupancy that differ in their cross-linking strategies and probe design. Cells are 
cross-linked with glutaraldehyde or formaldehyde or both, sonicated to generate smaller 
DNA fragments, hybridized with biotin conjugated DNA probes complementary to RNA of 
interest, and then the tertiary protein-DNA-RNA complex is purified with streptavidin beads. 
Upon cross-link reversals, the resulting DNA can be sequenced or the associated proteins 
could be analyzed by mass spectrometry. Specifically, chromatin isolation and purification 
(ChIRP) (Chu et al., 2011) uses a pool of 20nt long probes that tile the entire length of the 
lncRNA while capture hybridization analysis of RNA targets (CHART) (Simon et al., 2011) 
relies on using probes designed to target accessible binding sites with the help of RNase H 
mapping. Similarly, RNA-RNA interactions can be studied by using a variety of cross-linking 
chemicals that target both direct and indirect interactions, namely 4'aminomethyltrioxalen 
(AMT) that captures direct RNA-RNA interactions through uridine cross-links and a 
combined treatment of formaldehyde and disuccinimidyl glutarate (FA-DSG) that captures 
RNA interactions occurring via multiple protein intermediates (Engreitz et al., 2014) 
3.3 LNCRNA STRUCTURE 
LncRNAs could harbour relatively more conserved secondary structures that are important 
for their function. Despite challenges in structural analyses due to their size, RNA structural 
profiling methods that utilize chemical and enzymatic probing techniques have been 
developed. For example, selective 2′ -hydroxyl acylation by primer extension (SHAPE) 
(Wilkinson et al., 2006) relies on certain chemicals to modify more accessible regions of 
RNA like single strands and loops by adding 2‘-O-adducts while the highly structured 
regions are shielded. Modified regions are extended by target specific primers until the 
adduct and the extension length is used to build a secondary structure map. Using specific 
nucleases that cleave single stranded regions and then sequencing the resulting RNA 
fragments allows for a genome wide reconstruction of RNA secondary structure (Kertesz et 
al., 2010; Underwood et al., 2010). Therefore, these techniques hold a lot of potential in terms 
of linking lncRNA structure with its functionality. 
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Figure 2: Schematics of chromosome isolation by RNA purification (ChIRP) and individual nucleotide 
resolution, cross-linking and immunoprecipitation (iCLIP).  
Workflow of ChIRP involves cross-linking chromatin to RNA:protein in-vivo, tiling the lncRNA of interest with 
biotinylated probes, using streptavidin beads to bull down the chromatin complex and elute the lncRNA- DNA 
or protein complex with a mixture of RNase H and A. (Adapted from Chu et al.,2011) 
iCLIP workflow involves cross-linking RNA:protein through UV which results in a covalent bond at the site of 
contact. RNA is partially digested and the protein of interest is immunoprecipitated using an antibody. RNA is 
ligated with an adapter at 3’ end and for visualisation, labelled with radioactivity at the 5’ end. After running 
the complex on a SDS-PAGE gel followed by transfer onto a nitrocellulose membrane, the expected size is cut 
out and protein is digested with proteinase K. Reverse transcription is performed with two cleavable adapter 
regions and barcodes. After removing free RT primers through size-selection, cDNA is circularised and an 
oligonucleotide with a restriction enzyme site is annealed to it. Subsequent cleavage linearizes the cDNA and 
generates suitable template for PCR amplification and sequencing. (Adapted from Huppertz et al.,2014).  
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4 NEURODEVELOPMENT 
4.1 EMBRYONIC STEM CELLS 
Mouse embryonic stem cells (mESCs) are derived from the inner cell mass (ICM) of the pre-
implantation blastocyst. These cells would normally develop into the epiblast and eventually 
produce all adult tissues in-vivo while the outer trophoblast layer generates extra-embryonic 
tissue like the placenta (Evans and Kaufman, 1981). ESCs are defined by pluripotency and 
extended self-renewal properties. The molecular network that establishes and maintains these 
unique properties is driven by the combined action of three pioneering transcription factors 
essential for early development, namely Sox2, Nanog and Oct4 (Boyer et al., 2005). In 
addition to being critical for ES cell identity; Sox2 and Oct4 also orchestrate germ layer fate 
selection into neuroectoderm and mesendoderm, respectively (Thomson et al., 2011). The 
above-mentioned transcription factors are known to co-occupy hundreds of target loci 
resulting in feed-forward and auto-regulatory circuits (Boyer et al., 2005; Chen et al., 2008). 
Some of these multifactor-binding genes are expressed in ESCs but tend to be down regulated 
upon differentiation (Kim et al., 2008), which points to their significant role in maintaining 
ESC phenotype. In addition, the transcription factor triad interacts extensively with chromatin 
modulators such as histone deacetylases (HDACs), polycomb repressive complexes (PRCs) 
and SWI/SNF ATPase dependent remodeling components (Boland et al., 2014) to use 
repressive pathways for either silencing differentiation-promoting genes (Petell et al., 2016) 
or keep them transcriptionally poised with bivalent chromatin marks (Bernstein et al., 2006).   
4.2 NEUROGLIOGENESIS 
Further during mammalian embryo development, the ICM undergoes differentiation into 
germ layers consisting of ectoderm, endoderm and mesoderm through the process of 
gastrulation (Kiecker et al., 2016). While mesoderm gives rise to skeletal muscles, bone, 
cartilage and connective tissue; endoderm forms visceral organs like stomach and intestines. 
Ectoderm develops into surface ectoderm (epidermis, hair, nails), peripheral and central 
nervous systems (Kiecker et al., 2016). Early neurodevelopment comprises of the following 
sequential events (Zirra et al., 2016): the neuroepithelial cells or neural stem cells (NSCs) of 
the ectoderm proliferate to specify the neural plate through a process called neural induction. 
The neural plate eventually invaginates generating the neural tube. Here, the apical-basal 
polarization of neuroepithelial cells is followed by patterning of the neural tube into spatially 
and functionally distinct regions along the rostrocaudal (R-C) and dorsoventral (D-C) axes 
(Stern et al., 2006). Precursors for forebrain, midbrain, hindbrain and spinal cord are formed 
according to the R-C axis through interplay of different factors, some of which mark the 
barriers between different regions by their mutually exclusive expression pattern (Wilson and 
Maden, 2005). On the other hand, primary dorsal morphogenic cues is provided by bone 
morphogenetic protein 4 (BMP4) and Wnt mediated signaling while sonic hedgehog (Shh) 
and retinoic acid (RA) signaling is required ventrally and in the intermediate zone of the D-V 
axis, respectively (Wilson and Maden, 2005). Thus, distinct neuronal subtypes and glial cells 
are generated from discrete domains formed through opposing D-V morphogenic gradients. 
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4.3 OLIGODENDROGENESIS 
The glial population of the vertebrate nervous system consists of oligodendrocytes, astrocytes 
and microglia. Oligodendrocytes (OL) spirally wrap neuronal axons through their myelin 
containing membranes. Insulating properties of myelin allows for fast and efficient impulse 
transmission between neurons through saltatory conduction, which is crucial for meeting the 
energy demands of a higher order nervous system (Simons and Nave, 2015). In addition, OLs 
aid long term axonal integrity and survival by supplying energy metabolites to axons 
(Fünfschilling et al., 2012). 
4.3.1 Oligodendrocyte specification 
OLs are derived from oligodendrocyte precursor cells (OPCs), which in turn, arise from 
neuroepithelial cells lining the spinal cord canal and the ventricles of the embryonic brain 
(Richardson et al., 2006). 
Specifically, the first wave of precursors from a discrete ventral pMN domain in the spinal 
cord gives rise to motor neurons (E9-10.5) and subsequently (E12.5) to platelet-derived 
growth factor alpha-receptor (PDGFRα) positive OPCs (Richardson et al., 2000). As 
discussed above, Shh signaling is necessary for the establishment of ventrally derived OPC 
fate and acts through homeodomain transcription factors (Nkx6) and basic helix-loop-helix 
proteins (Olig2/1) (Lu et al., 2000; Vallstedt et al., 2005). Later during development (E15), a 
second wave of dorsally derived OPCs occurs, presumably through a Shh independent route 
(Cai et al., 2005). Ventrally derived OPCs are highly migratory and account for 
approximately 80% of spinal cord OPCs, while the remainder comes from dorsally derived 
OPCs (Fogarty et al., 2005; Vallstedt et al., 2005). 
The forebrain develops from the embryonic telencephalon where the OPCs arise sequentially 
in three spatio-temporal waves (Kessaris et al., 2006). The first wave appears at E12.5 in the 
ventricular/sub-ventricular zone from the medial ganglionic eminence (MGE) defined by the 
expression of homeobox protein, Nkx2.1. The second one marked by homeobox protein, 
Gsx2, occurs in the lateral-to-caudal ganglionic eminences (LGE/CGE) at E15.5 and the final 
wave expressing homeobox protein, Emx1, occurs postnatally in the cortex. Although, these 
precursors account for nearly all OL lineage cells in telencephalon at birth, Nkx2.1 
expressing precursors plummet and eventually disappear in adulthood (Kessaris et al., 2006). 
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4.3.2 Neuron-Glial switch 
During CNS development, gliogenesis requires a developmental switch from neurogenic 
programs to those that produce OLs and astrocytes. In the pMN domain, this is mainly 
facilitated by ongoing activity of Shh and Olig2 (Ravanelli and Appel, 2015) with Olig2 
presumably switching binding partners to initiate transition from motor neuron to OPC 
production (Li et al., 2011). This is accompanied by down regulation of proneural factors like 
neurogenin 2 (Ngn2) and promotion of a gliogenic phase by delta-like-NOTCH signaling 
(Zhou et al., 2001) with concomitant induction of transcriptional programs regulated by SRY-
box 9 (Sox9) and nuclear factor I (NF1) proteins (Kang et al., 2012). In the embryonic 
forebrain, the precise domain of OPC specification is not well understood.  Proneural factors, 
Ngn2 and Mash1 show mutual exclusion in the dorsal and ventral telencephalon, respectively 
(Ma et al., 1997). Astrocytic progenitor cells seem to derive from Ngn2 positive dorsal 
domain while early OPCs might develop from a MGE region with overlapping expression of 
Dlx2, Mash1 and Olig2/1, with an eventual co-operation of the latter two proteins (Parras et 
al., 2007). 
4.3.3 Myelination 
Following specification, OPCs proliferate and migrate throughout the CNS during early 
postnatal period, which is characterized by prolific myelination. Peptide mitogens like 
homodimeric PDGF-AA synthesized by neurons and astrocytes along with insulin growth 
factor-1 (IGF-1) and fibroblast growth factor-2 (FGF-2) enhance OPC proliferation and 
migration (Gard and Pfeiffer, 1993; Milner et al., 1997; Pang et al., 2007) by activating 
pathways that inhibit apoptosis and aid OPC survival (Frederick TJ., 2007). OPCs use spatial 
gradients of signaling molecules like BMP, Shh and Wnt to chemotactically migrate to their 
destination (Choe et al., 2014; Simpson and Armstrong, 1999), in addition to other local cues 
Figure 3: Multiple waves of OPCs are specified during the development of mammalian CNS 
a)  Three OPC waves arise in the forebrain ventricular zone during development; OPC 1 at E12.5 in the medial 
ganglionic eminence, OPC2 at E15.5 from lateral-to-caudal ganglionic eminences and OPC3 at birth from the 
cortex. b) Similarly, in the ventrally located pMN domain of the developing spinal cord, the first OPC1 wave 
arises at E12.5. The second OPC2 wave occurs dorsally at E15.5. A third OPC3 wave occurs at birth but its 
origin remains unclear.  (Adapted from Rowitch and Kriegstein, 2010) 
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of axonal guidance (Okada et al., 2007; Zhang et al., 2004), extracellular matrix components 
(Bribián et al., 2008; Garcion et al., 2001) and vascularization (Tsai et al., 2016). Notch and 
Wnt signals also inhibit premature OPC differentiation (Givogri et al., 2002; Guo et al., 2015) 
through downstream transcription factors like inhibitor of differentiation 2 (Id2), Id4 and 
Hes5.  
Proliferating OPCs exit cell cycle and start differentiating into oligodendrocytes due to both 
intrinsic and extrinsic cues. Intrinsic myelination programs involve successful induction of 
transcription factors that promote differentiation (Sox10, YY1, Tcf7l2, Myrf) and 
simultaneous dis-inhibition of differentiation (Id2, Hes5, Sox6) (Emery and Lu, 2015). 
Certain chromatin remodelers and transcription factors act as both repressors and activators 
of differentiation, depending on the developmental stage. For example, Tcf7l2 partners up 
with β-catenin during the late OPC stage to form a transcriptional complex that inhibits OL 
differentiation (Ye et al., 2009). Following downregulation of Wnt signaling (and β-catenin), 
Tcf7l2 interacts with  histone deacetylases 1/2  (HDAC1/2)  to repress the expression of OL 
differentiation inhibitors (Ye et al., 2009). Similarly, HDAC2 in conjunction with co-
repressor, NCOR, represses expression of Sox10 in NSCs (Castelo-Branco et al., 2014), 
while HDAC1 promotes differentiation by acting alongside transcription factor YY1 to 
relieve OL differentiation inhibition in OPCs (He et al., 2007). 
OL mediated myelination is capable of responding to external clues such as both axonal 
number and size (Almeida et al., 2011; Lee et al., 2012). Indiscriminate myelination is mostly 
avoided with inhibitory cues present on the axon and they include ligands such as jagged, 
PSA-NCAM and LINGO-1 (Jakovcevski et al., 2007; Mi et al., 2005). In addition to 
inhibitory axonal ligands, myelination could also be driven directly (Gautier et al., 2015; 
Stevens et al., 2002) or indirectly (Ishibashi et al., 2006) by neuronal activity. However, in 
the absence of neuronal activity, myelination still occurs but at slower rates (Lundgaard et al., 
2013). 
OPCs continue to cycle in the adult brain, post developmental myelination. Apart from 
maintaining a steady stem cell pool (Hughes et al., 2013), these OPCs play important roles in 
adaptive myelination or during injury to correct myelin deficits. Recent studies have shown 
that OPCs indeed generate new oligodendrocytes in response to neuronal plasticity that 
requires remodeling existing myelinated axons or production of new myelin (Gibson et al., 
2014; Sampaio-Baptista et al., 2013; Young et al., 2013. Further, OPCs proliferate and are 
capable of migrating to demyelinating lesions to ensure an efficient replacement of 
myelinating OLs (Gudi et al., 2014). 
Thus myelination is a process that harnesses OLs‘ underlying capacity to produce myelin and 
fine-tunes it by integrating a variety of region specific environmental cues in the CNS. 
4.3.4 Oligodendrocyte lineage heterogeneity 
As discussed above, it is clear that OPC populations exhibit a spatiotemporal developmental 
heterogeneity. However, ablation of each of the OPC population resulted in the remaining 
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OPCs repopulating the CNS without significant differences in myelination (Kessaris et al., 
2006). This finding was supported by a recent transcriptomic study, which reported a 
transcriptional convergence of post-natal PDGFRα positive OPCs irrespective of their 
developmental origin (Marques et al., 2018). Although this indicates a gross functional and 
transcriptomic equivalence between the populations, it is still unclear if they continue to 
maintain heterogeneity in other more nuanced ways to suit their local environmental needs. 
For example, postnatal OPCs from spinal cord produce higher myelin sheet length than those 
from the cortex (Bechler et al., 2015). Further, CNS is made up of two kinds of tissue: white 
matter (WM) which largely consists of long-range myelinated axons and grey matter (GM) 
which is made up of neuronal cell bodies, synapses and relatively fewer myelinated axons. 
Consistent with this observation, adult OPCs in white matter and grey matter exhibit different 
self-renewal capacities (Hill et al., 2013). The former has shorter cell cycle time and rapid 
proliferative capacity (Maki, 2017). WM OPCs were also found to have a higher propensity 
for differentiation into mature OLs compared to GM OPCs (Dimou et al., 2008). 
Furthermore, OPCs express glutamate receptors and can receive depolarizing synaptic inputs 
from axons (Káradóttir et al., 2005; Kukley et al., 2010; Spitzer et al., 2016). They also 
express voltage-gated sodium and potassium channels (FIELDS, 2008). The onset and 
expression of such electrophysiological properties in OPCs are reported to vary, both within 
and between brain regions and age (Chittajallu et al., 2004; Spitzer et al., 2019). In addition, 
electrophysiological properties seem to make OPCs more vulnerable to ischemic injury 
(Káradóttir et al., 2008). 
Although Rio Hortega recorded morphological diversity within OLs nearly a century ago, the 
underlying transcriptional landscape instructing different OL states along the differentiation 
pathway only became clear with the advent of large scale transcriptomic and proteomic 
studies in the last decade (Cahoy et al., 2008; Sharma et al., 2015; Zhang et al., 2014b). More 
clarity was achieved when the first single-cell transcriptomic study unveiled six distinct 
subpopulations of OLs in the mouse brain (Zeisel et al., 2015). This was further 
complemented by a second study in which twelve distinct clusters could be transcriptomically 
ordered to recapitulate the OL differentiation process in mouse juvenile and adult CNS 
(Marques et al., 2016). Though post-mitotic committed OPCs (COPs) and newly formed OLs 
(NFOLs) were present in all regions, mature OLs (MOLs) showed age and location 
dependant distribution (Marques et al., 2016). Whether the abovementioned MOL 
subpopulations correspond to functional sub-types in the CNS, is yet to be determined.  
 
 
 
 
 
Figure 4: Model of OL lineage 
progression based on single cell RNA-
seq datasets 
OL differentiation process is sequential 
and uniform in the CNS, until the 
myelin forming stage. Mature 
populations are heterogeneous and 
exhibit region specificity, with MOL1-4 
common in juvenile mouse and MOL5/6 
mostly present in the adult mouse. 
(Adapted from Marques et al., 2016) 
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5 MULTIPLE SCLEROSIS 
Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disorder of CNS affecting 
approximately 2.3 million people worldwide (Browne et al., 2014), predominantly young 
adults (Kobelt et al., 2017). Though the underlying cause of the disease is not well 
understood, studies point towards multiple factors involving complex gene-environmental 
interactions (Ascherio, 2013; International Multiple Sclerosis Genetics Consortium (IMSGC) 
et al., 2013; Ramagopalan et al., 2010). 
MS is usually viewed as a two-stage disease: an early inflammation phase resulting in 
demyelinated lesions, characterized by reversible neurological deficits (relapse-remitting MS) 
followed by a delayed neurodegeneration phase causing progressive, permanent clinical 
disability (secondary progressive MS) (Leray et al., 2010). Accordingly, demyelination is 
followed by proliferation and activation of resident OPCs into a regenerative phenotype 
(Fancy et al., 2004). The activated OPCs migrate to the site of lesion, make axonal contacts 
and differentiate into remyelinating OLs (Franklin and Ffrench-Constant, 2008). Eventual 
remyelination failure is linked to depletion of OPCs in plaques as well as reduced OPC 
migration and differentiation (Boyd et al., 2013; Hartley et al., 2014; Kuhlmann et al., 2008), 
owing to a dysregulated pathological environment (Franklin, 2002). 
The debates surrounding MS aetiology are centered on whether the disease starts with 
primary autoimmune attack as is traditionally believed (outside-in hypothesis) or if the initial 
trigger arises from within the CNS in the form of cellular and/or myelination dysregulation 
(inside-out hypothesis). 
Outside-in hypothesis: The strongest genetic risk for MS is within the MHC locus 
(International Multiple Sclerosis Genetics Consortium (IMSGC) et al., 2013) plus MS lesions 
are characterized by large infiltrates of immune cells (Frischer et al., 2009). Therefore, the 
historical view is that MS is principally mediated by auto reactive, pro-inflammatory effector 
T cells which make their way into CNS through a breakdown of the blood-brain barrier. In 
health, auto reactive T cells that escape thymic education are kept in check at the periphery 
by a unique population of FoxP3 positive regulatory T cells (Sakaguchi et al., 2007), while in 
MS this mechanism is rendered insufficient (Viglietta et al., 2004). Auto reactive T cells are 
then re-activated by antigen presentation from B cells and myeloid cells in the periphery and 
CNS (Jelcic et al., 2018), with suspected myelin related antigens. Widely implicated are the 
IL-17 producing effector CD4+ (TH17) and CD8+ T cells in establishing inflammatory 
lesions and OL damage, by recruiting additional T cells and macrophages (Huber et al., 2013; 
Kebir et al., 2007)).  
A commonly used outside-in experimental model of MS is autoimmune encephalomyelitis 
(EAE). EAE models are of different types. The passive T-cell transfer involves transfer of T-
cells from animals sensitized with brain tissue to induce neuroinflammatory response in naïve 
recipients (Paterson, 1960), mainly via CD-4
+
 T-cells. Since the T-cells have already 
undergone expansion in the host animal, this model does not need immune activation in the 
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peripheral lymphatic tissue to induce an inflammatory response. Co-transfer models involve 
inducing brain inflammation by passive transfer of auto-reactive T cells, followed by 
injection of auto-antibodies (Linington et al., 1988). Here, the inflammatory reaction is also 
associated with widespread primary demyelination. On the other hand, active sensitization 
models require immunization with a CNS antigen, usually with the MOG35-55 peptide, 
together with a strong adjuvant (Mendel et al., 1995). In this model, acute or chronic 
inflammatory encephalopathy results with primary axonal injury, but this CD-4
+
 auto-reactive 
T-cell mediated pathology is restricted to the spinal cord (Kim et al., 2006). 
Consistent with this view, therapies have been focused on correcting or limiting contributions 
of effector T cells to the disease but anti-CD20 mediated depletion of B cells have resulted in 
lower rates of disease activity in relapse MS patients (Hauser et al., 2017; Kappos et al., 
2011; Sorensen et al., 2014). Since antibody secreting plasma cells are unharmed in these 
therapies, B cells are thought to play an important role in triggering new MS relapses through 
their antibody-independent functions. For example, B cells are able to present protein 
antigens more efficiently at low antigen levels (Pierce et al., 1988) and EAE mice with B cell 
specific MHC-II KO have been found to be resistant to disease induction via recombinant 
MOG (Molnarfi et al., 2013). Apart from antigen presentation, B cells also express a number 
of co-stimulatory molecules essential for defining primary and secondary T cell responses 
(O‘Neill et al., 2007) along with co-inhibitory molecules involved in dampening effector T 
cell response (Bodhankar et al., 2013). B cells present abnormal pro-inflammatory cytokine 
profiles in untreated MS patients (Bar-Or et al., 2010; Duddy et al., 2007; Li et al., 2015a). 
Resulting elevated levels of IL-6 and GM-CSF are involved in generating TH17 and enhanced 
myeloid inflammatory responses (Barr et al., 2012; Li et al., 2015b), respectively.  Thus an 
updated view of MS pathogenesis accounts for the above mentioned B cell contributions. 
Inside-out hypothesis: According to this hypothesis, MS could be triggered from 
oligodendrocyte death which results in myelin damage. Myelin debris could enter the 
immune system as antigens following which the immune system erroneously perceives this 
as foreign and begins a full scale attack on myelin, thus initiating MS (Stys et al., 2012). 
Recently, a study demonstrated this possibility by ablating oligodendrocytes specifically with 
diphtheria toxin in a young Plp1-CreER
T
;ROSA26-eGFP-DTA (DTA) mouse model 
(Traka et al., 2016). Following oligodendrocyte loss and demyelination that resulted in 
CD-4
+
 T-cell infiltration into the CNS, the DTA mice developed a late onset secondary 
disease characterized by severe myelin and axonal loss. Subsequent studies have strengthened 
the possibility of brain intrinsic degenerative mechanisms inducing immune activation (Baxi 
et al., 2015; Scheld et al., 2016), including altered myelin structure (Caprariello et al., 2018). 
In a cuprizone autoimmune encephalitis (CAE) model, brief cuprizone treatment was used to 
disrupt myelin ultrastructure without overt demyelination, following which an immune 
stimulus was administered without the MOG peptide (Caprariello et al., 2018). CAE mice 
developed demyelinating immune response comparable to MS, which was significantly 
driven by biochemical alterations of myelin in the form of citrullination by peptidyl arginine 
deiminases (PADs). However, in other contradicting studies oligodendrocyte death was not 
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sufficient to induce immune activation, despite axonal damage, microglial-macrophage 
activation and draining of myelin material into lymph nodes (Locatelli et al., 2012; Pohl et 
al., 2011). 
Although, the pathological responses vary with different models, it seems like a combination 
of primary oligodendrocyte damage and a permissive immune system is required for MS to 
manifest.  
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6 LNCRNAS IN NEURODEVELOPMENT 
The mammalian CNS houses trillions of cells of neuronal and glial origin which are 
intricately integrated to form the functional circuitry of the brain.  Generating such diverse 
cellular architecture during neurodevelopment and maintaining it to facilitate successful 
adaptation during growth requires a co-ordinated expression of functional components of the 
genome. This is achieved by a complex interplay of transcriptional and epigenetic control 
mechanisms mediated by transcription factors and chromatin remodellers. A third and a 
relatively novel component of this regulatory network are lncRNAs. The greatest fraction of 
lncRNA expression is intriguingly observed in the brain and testis (Necsulea et al., 2014; 
Soumillon et al., 2013), which perhaps underlies the organisational complexity of these 
tissues. 
Indeed, lncRNA loci are preferentially found in the vicinity of protein coding genes that are 
highly expressed in the brain and are involved in CNS development (Ponjavic et al., 2009), 
suggesting a possible functional co-operation between the pairs. Many lncRNAs are 
dynamically regulated within the developing brain (Mercer et al., 2008) and show a striking 
cell-specific localization, along with restricted expression patterns within distinct 
neuroanatomical loci (Belgard et al., 2011; Goff et al., 2015; Sone et al., 2007). Thus it is not 
surprising many emerging studies have reported lncRNAs to play important roles in 
pluripotency, lineage specification, fate transition and neuronal and glial cell type elaboration. 
6.1 REGULATION OF PLURIPOTENCY 
The chromatin landscape of ES cells is globally more open and transcriptionally permissive 
(Efroni et al., 2008), yet only a subset of genes are robustly expressed. Further, promoters of 
many genes, particularly those involved in lineage specification, are kept poised for 
transcription, and carry bivalent activatory and inhibitory histone marks (Mikkelsen et al., 
2007). The most prevalent cellular method of transcriptional control is RNA pol II pausing 
(Adelman and Lis, 2012) and the small nuclear non-coding RNA 7SK plays a central role in 
this process. The highly conserved 330 nt ncRNA (Marz et al., 2009) associates with proteins 
such as La-related protein 7 (LARP7), hexamethylene bis-acetamide inducible 1 mRNA 
(HEXIM) 1/2 and methylphosphate capping enzyme (Mecpe) to form a canonical small 
ribonucleoprotein (snRNP) complex (Peterlin and Price, 2006). The resulting, 
conformationally altered, 7SK snRNP is known to sequester positive transcription elongation 
factor b (P-TEFb), thereby preventing phosphorylation of RNA pol II needed for successful 
elongation (Prasanth et al., 2010). Rather than being a passive reservoir of P-TEFb in the 
nucleoplasm, several studies raised the possibility that there could be chromatin proximal 
release of P-TEFb in response to appropriate stimuli (D‘Orso, 2016; McNamara et al., 2013). 
Particularly, in ES cells, 7SK was found to supress a specific cohort of lowly expressed 
genes, enriched for bivalent and active chromatin marks (Castelo-Branco et al., 2013). 
Surprisingly, it was also found to be important for transcriptional termination and regulation 
of promoter bidirectionality. Further insights came from investigating genome wide binding 
of 7SK and its in-vivo protein partners. 7SK was found to associate with the nucleosome 
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remodelling BAF complex at enhancers to limit enhancer RNA initiation and synthesis, while 
engaging in RNA pol II pausing at promoters through its canonical partners (Flynn et al., 
2016). Thus 7SK facilitates distinct molecular mechanisms to operate at different regulatory 
DNA elements in order to maintain the unique transcriptional landscape of ES cells necessary 
for pluripotency. 
Apart from 7SK, other lncRNAs employ diverse mechanisms to co-operate with transcription 
factors, RNA-binding proteins, epigenetic modulators and small RNAs to regulate and fine 
tune the maintenance of ES cell identity. A large scale functional study identified more than 
130 lincRNAs whose perturbation led to loss of ES cell pluripotency and many others which 
were essential for repressing lineage specific genes (Guttman et al., 2011). Not surprisingly, 
some of the lincRNAs were regulated by the core pluripotency transcription factors and about 
30% interacted with chromatin remodellers. Another functional study identified Tcl1 
upstream neuron associated lincRNA (TUNA), amongst others necessary for pluripotency, 
and found that the lincRNA associates with RNA-binding proteins to interact with promoters 
of Nanog, Sox2 and Fgf4 (Lin et al., 2014). LincRNA, regulator of reprogramming (Linc-
ROR), is a cytoplasmic RNA that is able to sequester mir-145 and de-repress the translation 
of critical pluripotency factors in human ES cells (Wang et al., 2013). Similarly, growth 
arrest specific transcript 5 (Gas5) regulated by Oct4 and Sox2, maintains TGFb signaling by 
protecting its receptor from miRNA mediated degradation to promote mouse ES cell self-
renewal (Tu et al., 2018). The histone modifier Wdr5 also interacts with many lncRNAs 
including those involved in maintaining self-renewal of ES cells, moreover its RNA-binding 
pocket has been reported to be crucial for enforcing active chromatin state (Yang et al., 
2014). 
6.2 REGULATION OF NEUROGENESIS 
Numerous studies have identified a dynamic change in chromatin status and expression for 
thousands of lncRNAs all the way from specification and differentiation of NSCs to glial fate 
specification and oligodendrocyte maturation 
6.2.1 Neural stem cell maintenance and differentiation 
Previously discussed lncRNA mediated modes of regulation like working with key 
transcription factors, chromatin remodelers and RNA-binding proteins to enact specific 
transcriptional programs can be found in this context as well. Brain specific 
rhabdomyosarcoma 2 associated transcript (RMST) was reported to interact with SOX2 and 
was necessary to recruit the transcription factor to a host of genes implicated in neurogenesis 
(Ng et al., 2013). Some embryonically expressed lncRNAs like TUNA also control neural 
lineage commitment by targeting neural gene promoters in differentiating ES cells (Lin et al., 
2014). LncRNAs like Dali and Paupar are transcribed in the vicinity of transcription factors, 
Pou3f3 and Pax6, respectively. In addition to regulating their transcription locally, the 
lncRNAs also physically interact with these transcription factors to influence the expression 
of distal genes involved in neural differentiation (Chalei et al., 2014; Vance et al., 2014).  
  25 
In contrast, the nuclear enriched lncRNA Pnky restrains neurogenesis from both embryonic 
and post-natal NSCs in several ways. During development, NSCs produce transit amplifying 
cells whose division gives rise to neuroblasts from which interneurons are generated in the 
olfactory bulb (Lim and Alvarez-Buylla, 2014). Ablation of Pnky results in increased 
neuroblast formation and a drastic decrease of NSCs (Ramos et al., 2015). Furthermore, Pnky 
interacts with the splicing regulator, PTBP1, and represses the inclusion of neuronal exons in 
transcripts involved in maintaining a specific cellular phenotype (Ramos et al., 2015). 
6.2.2 Regulation of brain circuitry and function 
A balance of excitatory and inhibitory neurons is essential for brain function. The Dlx class 
of homeobox proteins regulates the developmental pathway of producing inhibitory 
GABAergic neurons from the MGE. LncRNA Evf2 is transcribed downstream to Dlx5 in 
response to Shh signalling, and encompasses Dlx6 and an ultraconserved intergenic 
regulatory region important for controlling the Dlx5/6 bigene cluster. Initially, Evf2 was 
thought to act as a transcriptional co-activator with Dlx2 to activate the Dlx5/6 enhancer 
(Feng et al., 2006). However, when Evf2 was prematurely terminated with polyA insertion, 
there was an increase in Dlx5/6 levels even though the Evf2 KO mice showed reduced 
GABAergic interneurons in the embryonic hippocampus and loss of synaptic inhibition in the 
adult hippocampus (Bond et al., 2009). In addition to the expected loss of Dlx2 recruitment at 
the enhancer, there was also reduced recruitment of the transcriptional repressor, MECP2. 
Evf2 was also found to exist in a large ribonucleoprotein complex with Brg1 and inhibit its 
ATPase mediated chromatin remodelling activity (Cajigas et al., 2015), further contributing 
to the repressive outcome. Thus Evf2 recruits both activators and repressors to modulate the 
activity of the enhancer and the expression of Dlx proteins. 
Functional interactions between neurons require axon and dendritic growth to establish 
synaptic connections which is modulated by neuronal activity. Neuronal activity can 
restructure the epigenetic landscape to induce activity dependant genes through the release of 
neurotrophic factors (Su et al., 2017). Brain-derived neurotrophic factor (BDNF) promotes 
neuronal differentiation, synaptic growth and is essential for long-term memory (Hu and 
Russek, 2008). BDNF locus is under the control of a conserved lncRNA BDNF-AS, which 
negatively regulates BDNF expression by recruiting PRC2 to its locus (Modarresi et al., 
2012). Ion channels affect neuronal excitability, similarly lncRNA KCNA2-AS negatively 
regulates KCNA2 that encodes a core potassium channel subunit in DRG neurons (Zhao et al., 
2013). Additionally, specific mRNAs need to be transported away from the neuronal cell 
body to dendritic microdomains where their translation can be controlled in response to 
neuronal activity (Job and Eberwine, 2001; Steward and Schuman, 2001). The lncRNA BC1 
transported to dendrites upon its synthesis represses translation in the synaptic microdomain 
by interacting with the initiation factor eIF4A and polyA binding protein (PABP), thereby 
preventing the association of 48S pre-initiation complex assembly with dendritic mRNAs 
(Wang et al., 2005). 
 26 
6.3 REGULATION OF OLIGODENDROGENESIS 
Studies assessing the contribution of lncRNAs to OL biology have only begun in the last 
decade. The first systematic study in this field used microarray to study expression profiles of 
coding and non-coding RNAs during differentiation of NSCs in the embryonic forebrain 
(Mercer et al., 2010). Their developmental model examined NSC fate restriction to produce 
bipotent progenitors, oligodendrocytes lineage specification from Shh responsive progenitors 
and subsequent oligodendrocyte maturation into myelinating OLs. Similar to previous 
observations, some of the differentially expressed lncRNAs during these developmental 
transitions exhibited co-ordinated expression patterns with protein coding genes with well-
defined roles in glial lineage specification and elaboration. Further, histone deacetylation has 
been shown to be necessary for OL lineage progression (Marin-Husstege et al., 2002). 
Accordingly, following treatment with a HDAC inhibitor, majority of lncRNAs with specific 
expression profiles during oligodendrocyte differentiation were downregulated, which 
indicated their integration into a broader epigenetically regulated OL developmental program. 
A subsequent study integrated transcription factor occupancy data with glial and neuronal 
transcriptomes generated through RNA sequencing from mouse cortex to catalogue lncRNAs 
involved in OPC formation (Dong et al., 2015). This led to the identification of an OPC 
specific lncRNA, lnc-OPC, which had Olig2 binding in its upstream regulatory region. 
Further, loss of lnc-OPC resulted in reduced OPC numbers in-vitro, indicating its essential 
role in oligodendrogenesis.  
The first inclusive high quality catalog of lncRNAs in OLs came from deep sequencing 
primary mouse OPCs and oligodendrocytes that were differentiated with triiodothyronine 
(T3) for 1 day (immature OLs) and 3 days (mature OLs), respectively (He et al., 2017). This 
uncovered over 2000 oligodendrocyte specific lncRNAs, with more than 500 unannotated 
ones. Subsequent epigenetic profiling for histone marks and genomic occupancy of Sox10, an 
oligodendrocyte program inducting transcription factor, revealed these lncRNAs are 
dynamically regulated over the course of oligodendrocyte lineage progression. This led to the 
functional characterisation of lncOL1 (also termed as Pcdh17IT in Article 2) whose 
expression was highly correlated with the myeliogenic program. Accordingly, lncOL1 
deficient mice had lower OLs around birth and exhibited severe myelination deficits at the 
peak of myelination. Additionally, these deficits were also observed during remyelination 
following white matter injury. Mechanistically, lncOL1 was found to associate with Suz12 
mediated PRC2 complex to silence developmental programs that were antagonistic to OL 
differentiation, thereby allowing differentiation to proceed.  
Since this study, both bulk and single cell transcriptomic studies have expanded the repertoire 
of lncRNAs expressed in OL lineage cells (Marques et al., 2016, 2018; Zeisel et al., 2015) 
and have opened up the possibility to explore their functional contribution to glial biology. 
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7 SUMMARY OF ARTICLES INCLUDED IN THE THESIS 
7.1 INTERACTION OF SOX2 WITH RNA-BINDING PROTEINS IN MOUSE 
EMBRYONIC STEM CELLS 
Findings 
In this study, we determined the protein interactome of one of the key core pluripotency 
transcription factor, Sox2, in the chromatin and nucleoplasm fractions of mouse embryonic 
stem cells.  By using Stable Isotope Labelling by Aminoacids in Cell culture (SILAC) 
technology coupled with immunoprecipitation and mass spectrometry-based quantitative 
proteomics in a mouse embryonic cell line, we found Sox2 to be predictably interacting with 
other partner transcription factors and chromatin remodellers involved in stem cell 
maintenance. Interestingly, Sox2 also interacted with the heterochromatin 1 (HP1) family of 
highly conserved proteins, HP1 α, β, γ (Cbx5, 1 and 3) in both chromatin and nucleoplasm 
fractions. Further, this interaction was confirmed with human recombinant Sox2 or ES cell 
nucleoplasm extracts and with different modular domains of HP1.   
Gene ontology of Sox2 interactors in both the nuclear compartments indicated an enrichment 
of transcriptional regulators, a subset of which was RNA-binding proteins with known roles 
in post-transcriptional processes like splicing. Although it was shown previously that some 
Sox2 interactors like HP1a show RNA dependency in binding to chromatin (Muchardt et al., 
2002), we saw the interaction between Sox2 and HP1α/β persisted upon RNAse A treatment, 
indicating that the observed interaction is not dependent on RNA. 
In order to investigate the RNA interactome of Sox2 in the light of above findings, we 
performed immunoprecipation of Sox2 from formaldehyde cross-linked J1 ES cells, followed 
by poly(A)-neutral RNA-seq. While no lncRNAs were pulled down, there was an enrichment 
of a restricted subset of RNAs including ncRNAs, snRNA 7sk and snoRNA Snord34. 
Because 7SK regulates transcription at gene regulatory regions and Sox2 is a known pioneer 
transcription factor, we hypothesized that interaction between 7sk and Sox2 could play a role 
in their recruitment to the chromatin. To assess whether genomic recruitment of 7sk is altered 
in the absence of Sox2, we performed Chromatin Isolation by RNA Purification (ChIRP) 
with even and odd sets of probes against 7sk (Flynn et al., 2016) in a doxycycline inducible 
Sox2-knock out mES cell line and compared it with controls treated with DMSO. While 
specific and efficient pull down of 7sk was confirmed, we could not detect any changes in 
7sk binding following doxycycline mediated Sox2 KO. 
We then investigated whether 7sk could influence Sox2 binding and to this end performed 
Chromatin Immunoprecipitation (ChIP) with an endogenous Sox2 antibody in 7sk depleted 
mES cells with the help of an antisense oligonucleotide (ASO). Some of the genes that were 
found in the overlapping set between Sox2 and 7sk occupied regions (Kdm2b, Celf2 and 
Klf12) along with others known to be occupied by Sox2 (Pouf51 and Nanog) or shown to be 
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regulated upon 7SK knock down (Dll1), were chosen for qPCR assessment following ChIP. 
Though we observed specific Sox2 occupancy at these regulatory genes, knockdown of 7sk 
did not lead to significant changes in Sox2 binding.  
Therefore, snRNA 7sk and Sox2 though present in the same complex, do not influence each 
other‘s recruitment to the chromatin. 
Discussion 
Sox2 exists in multi-protein complexes, the composition of which is highly dependant on the 
cell type and purification technique. Our data, consisting of 124 proteins, provides a resource 
for the interactome of Sox2 in mESCs in different nuclear fractions. 
Some of the Sox2 interactors in the study belong to the heterochromatin 1 (HP1) family. 
While it is well known that HP1 co-localises with H3K9 methyl-transferase, Su(var)3-9, in 
heterochromatic regions to confer transcriptional repression (Hiragami and Festenstein, 
2005), it can also trigger repressive chromatin structures at specific promoters within 
euchromatic regions (Vandel et al., 2001). Further, HP1 and H3K9me3 were found on active 
genes within coding regions, where the localisation of HP1 was dependant on RNA pol II 
elongation (Vakoc et al., 2005). In the context of pluripotency, a study found that knock 
down of HP1γ enhances reprogramming of somatic cells into induced pluripotent stem cells 
(iPSCs) (Sridharan et al., 2013). Accordingly, HP1γ was found to bind upstream of Nanog 
TSS in intermediate pre-iPSCs and repress its expression, in conjunction with H3K9me3 
function. In contrast, HP1γ binding was also found within highly transcribed genes in both 
pre-iPSCs and ES cells, albeit with a distinct binding profile between the two cell types.  
Thus, there is a possibility wherein Sox2 can aid HP1‘s specificity in binding to the genome 
or participate in stabilization of transcription or elongation indicated to be supportive of in-
vivo HP1 binding within active euchromatic region in ES cells. 
Our data also indicates Sox2 to interact with ncRNAs, 7sk and Snord34. Interestingly, 
snoRNAs have been recently shown to exhibit genomic occupancy (Sridhar et al., 2017) and 
regulate chromatin/nuclear structure (Schubert et al., 2012). While Sox2 and 7sk might not 
modulate each other‘s recruitment to chromatin, they could be associated functionally in 
other ways. For example, poly ADP-ribose polymerase 1 (PARP-1), a Sox2 interactor in our 
study, was not only shown to stabilize Sox2 binding to chromatin (Liu and Kraus, 2017),  but 
also inhibited the negative elongation factor (NELF) by post-translational modification, 
thereby allowing transcriptional elongation to proceed (Gibson et al., 2016). The interaction 
between Sox2 and 7sk could be mediated by RBPs, namely Srsf1 and hnRNAPA2/B1, which 
are Sox2 interacting partners. While Srsf proteins recruit 7sk to promoters and mediate 
transcriptional pause release (Ji et al., 2013), hnRNPA2/B1 is involved in dynamic 
remodeling of 7SK snRNP in the nucleoplasm (Barrandon et al., 2007; Van Herreweghe et 
al., 2007). 
Alternatively, it remains a possibility that the association between Sox2 and the RNAs 
reported here is a consequence of their proximity on DNA and nucleoplasm and not 
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necessarily due to any functional relationship. Future investigations might unveil whether the 
presence of Sox2 in ribonucleoprotein complex carries any significance either to the 
functionality of Sox2 or its partner RNAs. 
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7.2 ROLE OF LNCRNAS PCDH17IT AND 2610035D17RIK IN 
OLIGODENDROCYTE LINEAGE PROGRESSION 
Findings 
LncRNAs are known to carry out diverse roles in cellular functions, yet their role in OL 
function remains unexplored. We have established a broad transcriptomic resource from two 
datasets. They correspond to single cell RNA sequencing on 5072 cells of the OL lineage 
from mouse juvenile and adult CNS together with both bulk and single cell RNA sequencing 
on Pdfgrα positive cells from E13.5 and P7 mouse brain and spinal cord. As discussed earlier, 
these datasets revealed a spatial and transcriptomic convergence of Pdfgrα positive OPCs 
during development (Marques et al., 2018) and also identified several well defined 
populations of OL cells reflecting unique stages along the process of differentiation and 
myelination (Marques et al., 2016). Therefore, we took advantage of these datasets and 
identified 938 annotated ncRNAs to be differentially regulated in the bulk RNA-seq dataset, 
between postnatal OPCs in the brain/spinal cord versus those from embryonic 13.5 
brain/spinal cord. Analysis of the single-cell RNA-sequencing dataset led to the identification 
of 267 ncRNAs differentially expressed between different OL sub populations, with a subset 
of these overlapping between the two datasets. Co-expression analysis between protein 
coding genes and non-coding RNAs resulted in four distinct clusters enriched for gene 
ontological terms associated with OL biology and function, such as myelination, synapse 
assembly or cell division. 
Further, we identified cluster 1 specific lncRNA 9630013A20Rik (also referred to as lncOL1 
in He et al., 2017) to be specific for the post-mitotic committed OPC (COP) and newly 
formed oligodendrocyte (NFOL) sub-populations. We named it Pcdh17IT (localised to the 
intron of Pcdh17 gene) in accordance with the HUGO nomenclature (Wright, 2014). While a 
knock down of Pcdh17IT in the mouse oligodendrocyte lineage cell-line olineu did not 
change the expression of Pcdh17 gene, it led to the downregulation of Tcf7l2, a transcription 
factor specifically expressed in NFOLs. In line with previous results, we also observed 
decreased expression of Mog, which is expressed in later stages of oligodendrocyte 
differentiation and an increase of Egr1, a repressor of oligodendrocyte differentiation that is 
downregulated in COPs.  
Similarly, another COP and mostly NFOL specific lincRNA 2610035D17Rik was found to 
co-localise with Itpr2, a marker for COPs, but not with cd140a, which largely labels OPCs in 
primary mouse OPC cultures differentiated for 48h. This lincRNA is transcribed from a 
region between Sox9 and Slc39a11 genes on chrm 11. Sox9 is a transcription factor with an 
important role in OL specification (Stolt et al., 2003) and more importantly, we found the 
expression of Sox9 mRNA and 2610035D17Rik transcript to be anti-correlated in postnatal 
primary OPCs.  Because lincRNAs are known to regulate their neighboring genes, often 
through cis mediated mechanisms, we decided to further investigate any role 2610035D17Rik 
might have in Sox9 regulation. 
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To this end, we performed Chromatin Isolation by RNA Purification (ChIRP) with even and 
odd sets of probes against 2610035D17Rik transcript in oli-neu resulting in a successful 
pulldown of 2610035D17Rik. qRT-PCR of ChIRP DNA indicated  that  2610035D17Rik 
interacts with the Sox9 genomic locus. However, siRNA mediated knockdown of both 
2610035D17Rik and its positionally conserved human homologue, Linc00673 (SLNCR1), did 
not significantly affect the expression of SOX9 mRNA. Thus the partial loss of 
2610035D17Rik RNA or its human homolog does not affect the expression of their 
neighboring gene Sox9, despite our finding that this lincRNA interacts with the Sox9 locus. 
In order to differentiate between the effects of transcription/DNA locus from the transcript 
itself, we created a 2610035D17Rik KO oli-neu cell line by deleting a portion corresponding 
to lincRNA exon 1 using CRISPR-Cas technology. Strikingly, we also observed an 
upregulation of Sox9 mRNA and Sox9 protein in the KO cell lines, while no changes were 
observed on the expression of the other neighboring gene, Slc39a11. Further, ectopic 
expression of 2610035D17Rik from a plasmid in the KO cells did not return Sox9 to its 
baseline expression. Chromatin immunoprecipitation (ChIP) with H3K4me3 showed an 
enrichment of the active transcriptional epigenetic mark on Sox9 promoter compared to the 
control. Thus the observed upregulation of Sox9 in the KO cell line is partly achieved 
through epigenetic modification of Sox9 promoter via H3K4me3. 
In order to understand the global transcriptional effects of the KO of 2610035D17Rik, we 
performed total RNA-sequencing on control and three 2610035D17Rik KO clones. 
Differential gene expression and gene ontology analysis indicated an enrichment of 
upregulated genes involved in interferon response while there was trend for those involved in 
antigen processing and presentation to be downregulated in the KO cells compared to the 
control. We have recently shown that interferon gamma (IFNγ) can induce oligodendroglia to 
acquire immunological properties (Falcão et al., 2018). Accordingly, stimulation of KO and 
control oli-neu cells with IFNγ for 24h followed by qRT-PCR confirmed downregulation of  
Interferon Regulatory Factor I (IRF1) and Interferon Induced with Helicase C Domain 1 
(Ifih1) genes in KO oli-neu. In contrast, induction of genes associated with MHC-II 
(histocompatibility 2, class II antigen A (H2-aa)) and class II major histocompatibility 
complex transactivator (Ciita) was stronger in KO oli-neu cells in comparison with the 
control. These results suggest 2610035D17Rik also has a role in regulating immune responses 
of oligodenroglia in response to IFNγ stimulation. 
In sum, we have drawn on insights regarding lncRNAs from a broad transcriptomic resource 
established from single cell- as well as bulk RNA- sequencing of OL lineage cells from 
different developmental stages. We have pursued candidate lncRNAs whose expression was 
found to be specific for certain OL subpopulations and report two lncRNAs with distinct 
roles in OL lineage progression. 
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Discussion 
LncRNAs from this study were found to be dynamically expressed throughout the process of 
OL differentiation, with a cohort showing highly restricted expression to specific OL 
subpopulations, of which Pcdh17IT and 2610035D17Rik are examples. Pcdh17IT was shown 
to regulate Tcf7l2, a transcription factor with similar expression profile as the lncRNA. 
Further, knockdown of Pcdh17IT led to decrease of Mog, a myelin component, and increase 
of Egr1, an OL differentiation repressor, which is consistent with its role in regulating the 
onset of myelination program as reported in He et al., 2017. LincRNA 2610035D17Rik is 
transcribed 200kb downstream of the transcription factor Sox9 and is anti-correlated with its 
expression. We show that rather than the 2610035D17Rik transcript, the DNA locus from 
which it is transcribed or the act of transcription is involved in regulating Sox9 expression in 
oli-neu cells. Consistent with this observation is the presence of H3K27ac, a hallmark of 
active enhancers, within the 2610035D17Rik locus.  
Further, models of gene expression regulation have graduated from centering only 
transcription factors and regulatory DNA elements to include the full context of chromatin. 
Therefore, chromatin interactions occurring in three dimensional nuclear space, along with 
architectural proteins and RNAs that facilitate them have gained further focus.  The CCCTC-
binding factor (CTCF) is a unique DNA binding protein that can insulate DNA regulatory 
regions from one another (Bell et al., 1999). It can also be seen demarcating the boundaries 
between distinct active and repressive chromatin states (Cuddapah et al., 2009) as well as 
self-interacting, highly conserved, genomic regions called topologically associated domains 
(TADs). TADs are thought to facilitate interactions between regulatory elements within, than 
across TADs (Dixon et al., 2012). Another architectural protein that co-localises with CTCF 
and mediates long range genomic interactions is cohesin (Parelho et al., 2008; Rubio et al., 
2008). The heterodimeric subunits of cohesin form a ring-shaped structure that can 
encompass two chromatin fibres (Nasmyth and Haering, 2009). While strong cohesin sites 
overlap with CTCF binding, there are many weaker sites that overlap with active promoters, 
enhancers along with mediator complexes and tissue-specific transcription factors bound to 
these regions (Faure et al., 2012; Schmidt et al., 2010). Further, transcription has been 
reported to evict CTCF from chromatin (Lefevre et al., 2008) and displace cohesin by making 
it slide along the gene (Borrie et al., 2017).  
We find CTCF binding sites within 2610035D17Rik intron and preliminary investigation of 
Hi-C data in NSCs (Bonev et al., 2017) indicates the presence of a TAD that encompasses the 
region between 2610035D17Rik intron and Sox9. Given how the act of ncRNA transcription 
along with accompanying chromatin modifications can profoundly affect chromatin 
conformation and hence gene expression (Hirota et al., 2008), we are currently exploring a 
possible interplay between enhancers within the 2610035D17Rik locus and architectural 
proteins, CTCF and cohesin, in regulating Sox9 expression. During development, Sox9 is 
expressed in neural and OPCs before being downregulated at the onset of OL differentiation 
(data from Marques et al., 2016; Rosenberg et al., 2018) when 2610035D17Rik starts to be 
expressed. Accordingly, we hypothesize that chromatin contacts are made within the 
  33 
abovementioned TAD, between enhancers at the 2610035D17Rik locus and Sox9, to facilitate 
Sox9 expression in NSCs and during OPC specification. Stable transcription of 
2610035D17Rik in NFOLs during differentiation, either evicts CTCF from the lincRNA 
locus or results in a local displacement of cohesin thereby disrupting the enhancer-Sox9 
contacts, leading to downregulation of Sox9. 
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7.3 DISEASE SPECIFIC OLIGODENDROCYTE LINEAGE CELLS ARISE IN 
MULTIPLE SCLEROSIS 
Findings 
Multiple Sclerosis (MS) is characterized my immune mediated attack on myelin, which is 
produced by OLs. In order to investigate whether this attack is directed towards specific OL 
populations, we isolated single cells from the spinal cord of control and EAE mice. OL 
lineage cells were collected at the peak of disease (score=3) via sorting for GFP+ cells from 
EAE-induced Pdgfra-H2B-GFP transgenic mice and Pdgfra-Cre-LoxP-GFP7, enriching for 
OPC and OL populations, respectively. Smart-seq2 single cell RNA-seq and clustering 
analysis revealed thirteen OL clusters (four OPC, one COP, one NFOL and 8 MOL clusters). 
A subset of the OPC (OPCcyc, OPC2,3) and OL (MOL1/2, MOL5/6a and b) subpopulations 
were enriched in EAE mice and showed distinct expression profiles compared to healthy 
controls. More importantly, decomposition of datasets resulted in two gene modules uniquely 
associated with EAE, and consisted of genes involved in interferon response pathways, 
MHC-I and II genes (module 1) and Plin4, Hif3a and Fam107a restricted to MOL5/6 EAE 
population (module 13). Further, specific isoforms of genes involved in myelination like 
Mbp, Mobp, Pdgfa and Ifih1 were found in EAE, some of which have been previously 
reported in MS associated polymorphisms (Capello et al., 1997; Enevold et al., 2009). 
MHC-I molecules are found on surface of cells and are used to display non-self peptides from 
within the cytosol to cytotoxic T-cells to trigger an immune response (Hewitt, 2003). Some of 
the genes involved in this process (H2-K1, H2-D1, B2m, Tap1/2) were elevated upon EAE 
induction in OLs as well as OPCs, which makes them a potential target for cytotoxic T-cells. 
On the other hand, MHC-II expression is restricted to immune cells (microglia, macrophages) 
and are used to present processed exogenous antigens to CD-4
+
 T-cells (Holling et al., 2004). 
Surprisingly, a subset of OPCs and OLs expressed genes required for a MHC-II mediated 
response (H2-aa, H2-ab1, H2-eb1, cd74) and those involved in interferon response (Ciita, 
Nlrc5, Ifih1 etc). 
In order to understand the mechanisms triggering MHC-II expression, OPCs were co-
cultured with CD45
+ 
immune cells from spinal cord of EAE mice. 72h of co-culturing 
resulted in about 4% OPCs expressing MHC-II, pointing towards factors secreted by immune 
cells influencing MHC-II expression. Since MHC-II induction was previously reported in rat 
OPCs treated with dexamethasone and IFN γ ((Bergsteindottir et al., 1992), we treated mouse 
OPCs with IFN γ and/or dexamethasone for 3d and observed that just IFN γ treatment was 
sufficient to induce MHC-II expression. 
Further, we treated OPCs with 1μM fluorescent microspheres for 24h and observed OPCs 
could internalize several microspheres and this uptake was sensitive to cytochalasin, a 
phagocytosis inhibitor. This observation was also extended to the uptake of pHrodo-labeled 
myelin (a pH-sensitive fluorogenic dye that fluoresce red in acidic phagosomes). These 
findings suggest that OPCs are capable of phagocytosis with implications of myelin debris 
intake in a disease context. 
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To assess the impact of MHC-II expressing OPCs on T-cells, OPCs (controls, IFNγ and/or 
MOG35-55 treated) were co-cultured with CD4+ T cells (naïve, memory and effector) derived 
from 2D2 mice, where T cells express the T cell receptor for the MOG35-55 peptide. This was 
followed with flow cytometric analysis of T cells for survival, proliferation and cytokine 
production. While there was no effect on naïve T-cells in any of the conditions, we observed 
enhanced survival and proliferation of memory CD4+ T cells in presence of both non- and 
pre-IFNγ stimulated OPCs and the MOG peptide. Similarly, we observed that effector CD4+ 
T cells proliferated more in the presence of both non- and pre- IFNγ stimulated OPCs and 
MOG peptide. Effects mediated by non-stimulated OPC on T cells in the above mentioned 
cases could be explained by increased cytokine production in the presence of MOG peptide 
for memory T-cells and just the presence of OPCs for effector T cells.  
In sum, we have identified new biomarkers for EAE specific OL lineage cells and 
strengthened the possibility of OL lineage cells being active participants in inflammatory 
demyelinating pathology through immunomodulatory properties like phagocytosis and 
antigen-presentation.  
Discussion 
According to inside-out hypothesis, MS could be triggered from within the CNS with 
oligodendrocyte death or myelin dysregulation as discussed previously (Traka et al., 2016). 
Whether the EAE specific OL lineage cells presented here play any role in triggering an 
immunologic attack by antigen-presentation remains to be investigated.  
Another complementary study has recently investigated the role of cytokine signaling on 
OPC function (Leslie K et al., bioRxiv 2018). While both IFNγ and IL-17 (cytokines secreted 
by effector CD4+ T cells) inhibited OPC differentiation, IFNγ additionally induced the 
expression of MHC-I and II along with immunoproteasome subunits in-vitro and in-vivo. 
Immunoproteasome usually expressed by immune cells is involved in processing of antigens 
for presentation through MHC-I, to facilitate surveillance by the adaptive immune system 
(Ferrington and Gregerson, 2012). Futher, OPCs were capable of engulfing and processing an 
exogenous OVA peptide or the whole protein and present it with MHC-I molecule through 
the transporter associated with antigen processing (TAP1) pathway, following IFNγ 
stimulation. OPCs with OVA loaded MHC-I complex could also activate OVA specific 
CD8+ T cells. Consequently, CD8+ T cells induced contact dependent apoptosis of their 
target OPCs through upregulated Fas ligand on their surface. In our study, we see that even 
healthy OPCs are capable of internalizing particles from their environment which probably is 
a part of their homeostatic function. One possibility is the co-option of this function in a 
complex inflammatory milieu to activate CD8+ T cells in the CNS, thus becoming targets of 
depletion, as is documented in MS.  
The transcriptomic haul that occurs during EAE points towards lncRNAs as being possible 
contributors to the disease, given their role as gene expression regulators. Indeed, aberrant 
lncRNA expression has been detected in serum (includes NEAT1, 7SK) and blood cells of 
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relapse remitting MS patients (Eftekharian et al., 2017; Santoro et al., 2016). LncRNAs have 
also been reported to be involved in MS pathogenesis in microglia and T-cells (Sun et al., 
2017; Zhang et al., 2017a). In article 2 of this thesis, we implicate 2610035D17Rik lincRNA 
in regulation of immunomodulatory properties of oli-neu. 2610035D17Rik KO cells show 
decreased expression of IFNγ responsive genes and an increased expression of MHC-II 
related genes, in response to IFNγ stimulation. These two responses have been co-occurring 
in EAE specific OPCs and OLs, so it remains to be seen what the lincRNA mediated 
differential regulation of these events means in the disease context. Interestingly, in a 
transcriptomic profiling of spinal cord contusion (Chen et al., 2013), we observe Sox9 
expression increases at 2d post-lesion (dpl) and returns to base-line at 7dpl during 
regeneration, while the expression of 2610035D17Rik remains down by about 30% during 
these periods. Therefore, 2610035D17Rik mediated Sox9 regulation could also be important 
in the remyelination process. 
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7.4  MYEF2 INTERACTS WITH RNAS WITH CUG MOTIFS IN 
OLIGODENDROCYTES 
Findings 
Myelin gene expression factor 2 (Myef2) is a transcriptional repressor of Myelin Basic 
Protein (MBP) and hence plays an important role in regulating the timing of myelination at 
the onset of oligodendrocyte differentiation. It also harbours three RNA Recognition Motifs 
(RRMs) whose contribution to protein function in oligodendrocytes is largely unknown. In 
this study, we investigated the mechanism of action of Myef2 in the oligodendrocyte lineage. 
Using individual nucleotide resolution UV crosslinking and immunoprecipitation (iCLIP) 
followed by sequencing, we characterized the RNA interactome of Myef2 in the 
oligodendrocyte cell line, oli-neu, from the two bands on the autoradiograph — an expected 
lower band at 70KDa, corresponding to the molecular weight of Myef2 and an unexpected 
upper band. We obtained 641 and 143 peaks which could be mapped to a single genomic 
position for Myef2 upper and lower bands, respectively. About 65% and 33% of peaks from 
Myef2 upper band and lower band were found to be unique. Myef2 was observed to cross-
link to 64.58% of transcripts from protein coding genes. Significant peaks from the upper and 
lower Myef2 bands were found mostly within introns and 3‘UTRs of protein-coding genes. 
Gene Ontology (GO) on genes bound by Myef2 implicates it in biological processes such as 
cell adhesion, transcriptional regulation and mRNA processing. We could also find a 
predominant CUG motif within the hexamers from the sequences bound by peaks from both 
the upper and lower Myef2 bands. 
Discussion 
Myelin gene expression factor 2 (Myef2) acts as a transcriptional repressor of Myelin Basic 
Protein (MBP) by binding to its proximal DNA regulatory element and hence plays an 
important role in regulating the timing of myelination during development. It also harbours 
RNA binding domains in the form of three RNA Recognition Motifs (RRMs), whose 
contribution to Myef2 function has not been explored. A study from our lab identified Myef2 
in the protein interactome of Peptidyl Arginine Deiminase 2 (PADI2) which was found to 
play a role in modulating oligodendrocyte differentiation (Falcão et al., 2019). Interestingly, 
an arginine residue near the second RRM of Myef2 was citrullinated by PADI2. In order to 
understand the role of Myef2 in oligodendrocytes from the perspective of a RNA binding 
protein, we used individual nucleotide resolution CLIP (iCLIP) to capture the RNA 
interactome of Myef2. We find that Myef2 is capable of binding transcriptome-wide, 
especially within introns and 3‘UTRs of protein-coding genes, implicating it in post-
transcriptional processes like splicing and RNA stability. Known post-transcriptional 
regulators like poly-pyrimidine tract-binding protein and hnRNP C are reported to bind to 
43% and 55% annotated genes , respectively (König et al., 2010; Xue et al., 2009) indicating 
a similar post-transcriptional role for Myef2. Furthermore, a CUG motif occurs 
predominantly amongst hexamers from the sequences bound by Myef2. Currently, we are in 
the process of sequencing Oli-neu cells in which Myef2 has either been knocked down or 
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over-expressed to explore the levels or splicing patterns of those genes which Myef2 binds, in 
our iCLIP data. 
 
8 CONCLUSION 
My doctoral thesis has covered a wide range of topics from characterization of long non-
coding RNAs and RNA-binding proteins in different cell types using genome wide, high-
throughput techniques to single cell transcriptomic analysis of OL lineage cells in a mouse 
model of Multiple sclerosis (MS).  
A couple of insights gained from workings of lncRNAs are as follows: Combined action of a 
ncRNA involved in generic transcriptional control and a pioneering transcription factor with 
specialized role in maintaining pluripotency, provides a versatile way to adapt universal gene 
regulatory programs into cell- specific contexts. Also, a subset of lncRNAs restricted to 
certain sub-populations within a lineage, mediate transitions between different epigenetic 
states by forming regulatory networks with transcription factors and chromatin remodelers. 
Further, it is becoming increasingly clear that long and short range chromatin interactions are 
not only necessary for genomic organization but such an organization underscores many key 
gene regulatory principles. As such, lincRNA 2610035D17Rik mediated regulation of Sox9 
in OLs could shed more light on the complex teamwork operating between chromatin 
topology, non-coding loci and induction of development-specific gene expression programs.  
OL lineage cells have revealed themselves to be much more versatile in function, both in 
health and disease, than previously imagined. Immunomodulatory properties of OPCs in EAE 
mice involve antigen presentation and processing, along with activating memory and effector 
T cells. The expression of MHC-I/II genes can also be induced in-vitro by IFN γ treatment of 
OPCs. Interestingly, treatment with IFNγ results in the downregulation of lincRNA 
2610035D17Rik in WT OPCs. This dynamic could somewhat change in the 2610035D17Rik 
KO cells, which might manifest as immunological properties that are different than the 
WT/controls.  The functional implications of such a change need further investigation. 
.Normal OPCs are capable of phagocytosing 1 µm beads in a process that is sensitive to 
inhibition of actin polymerization, while internalization of myelin debris is intriguingly 
immune to it. These observations suggest OPCs have multiple ways of up taking material 
from their environment.. Future studies are needed to address the dynamics of OPC mediated 
phagocytosis and clearance of the internalized material and its subsequent effect on OPC 
function, during development and disease.  
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